Immutep Limited announced positive Phase I results for IMP761, its LAG-3 agonist antibody, demonstrating significant and dose-dependent suppression of T-cell immune responses in healthy volunteers. The drug was well tolerated across seven dose levels with no serious adverse events, supporting a four-week dosing interval. These findings suggest potential for treating autoimmune diseases by controlling pathogenic T cells. The ongoing multiple ascending dose study will provide further data, with results expected in the first half of 2027 to guide Phase II development.
IMP761 data from Immutep Limited provides context for readers. For those following the health sector, 88 of 150 US stocks rose and 62 fell on Pluang. Notable movers as of Nov 09, 2026 04:51 WIB include SMMT at USD 16.33 (+15.08%), NTRA at USD 310.67 (-14.59%), and DNA at USD 11.29 (+13.35%).
NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...
Bitcoin's open interest in perpetual futures reached $7.33 billion, the highest among five major crypto assets, with a 1.96% increase over 24 hours and a mark price of $75,854. Long positions dominate at 75.7%, supported by a funding rate of 0.0100% ...
Binance has resumed withdrawals for the altcoins HYPE and APT ahead of schedule as part of its recovery from the $6.3 billion hack on October 29, 2026. Data from Cryptoquant shows Binance's bitcoin reserves have decreased by about 56,000 BTC and ethe...
IREN mined only 402 Bitcoin in Q3 2023, down sharply from 2,039 in Q3 2022, as it transitions to an AI cloud business expected to complete by December 31. Its Bitcoin mining revenue dropped 88% to $28 million, with an average operating hashrate falli...
TokenPost.ai Strategy held 849,327 Bitcoin as of November 1, valued at about $63.58 billion, which is approximately $500 million less than their total purchase cost of $64.08 billion. The company bought 811 BTC for $65.5 million during the week endin...
